Press Release
SoluLinK, Incorporated
9853
Pacific Heights Blvd. Suite H,
San Diego, California 92121
Phone: 858.625.0670
Fax: 858.625.0770
solulink@solulink.com
Solulink Incorporated and EMD Biosciences, Inc. ink licensing agreement
MADISON, WI, January 18, 2005: Solulink Incorporated (Solulink), a company that provides conjugation
products and services for the conjugation of proteins, oligonucleotides,
peptides and antibodies to one another and to solid surfaces
for array, research assay, diagnostic and therapeutics applications, today announced that it has signed a licensing agreement
with EMD Biosciences, Inc. (EMD Biosciences), a major supplier
of premium tools for proteomics and disease pathway analysis
known through its global brands Calbiochem®, Novabiochem®,
and Novagen®. EMD Biosciences is part of the Life
Science and Analytics (LSA) division of Merck KGaA (Darmstadt, Germany) and operates as EMD Biosciences,
Inc. in North America and Merck Biosciences outside North America.
Under
the agreement, EMD Biosciences will license rights to use the
Solulink conjugation chemistry.
"Solulink is excited to have EMD Biosciences, a top-tier proteomics
provider with global reach, recognize the utility of Solulink's
HydraLinK conjugation technology," commented Steve DeGraw, CBO
of Solulink. "We are pleased to assist EMD Biosciences' research
and product development efforts."
"We
are pleased to enter into this agreement with Solulink," commented
Dr. Robert Mierendorf, Chief Technology Officer, EMD Biosciences.
"The HydraLinK chemistry has performed well in our applications,
and has allowed for increased flexibility in product design
and development.
About SoluLinK
SoluLinK is a leader in the development of advanced biological
reagents and custom services for the life sciences, diagnostic,
and nanotechnology research communities. Specifically, SoluLinK
(a privately-held company located in San Diego, California)
develops, manufactures, and markets bioconjugation products
and services. SoluLink’s proprietary bioconjugation linking
chemistry is used to link proteins, oligonucleotides, peptides,
and antibodies to each other or to a wide range of surfaces.
A rapidly growing application for SoluLink’s linking technology
include conjugation of biomolecules to solid surfaces for diagnostic,
therapeutic, and/or microarray products. SoluLinK’s proprietary
biotinylation reagent ChromaLink® Biotin is one more example
of a new product that is helping to enhance the performance
of more defined biotin-antibody conjugates used by a wide spectrum
of customers. SoluLinK markets these products directly and through
distributors/licensing partners, world-wide.
For
more information, please contact Solulink directly:
SoluLinK - The Conjugation Company
9853 Pacific Heights Blvd. Suite H,
San Diego, California 92121
Toll Free: 888.625.0670
Phone: 858.625.0670
Fax: 858.625.0770
solulink@solulink.com |
